Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Neoplasms and SLC5A8[original query] |
|---|
| Protein expressions and genetic variations of SLC5A8 in prostate cancer risk and aggressiveness. Urology 2011 Oct 78 (4): 971.e1-9. Lin Hui-Yi, Park Hyun Y, Radlein Selina, Mahajan Nupam P, Sellers Thomas A, Zachariah Babu, Pow-Sang Julio, Coppola Domenico, Ganapathy Vadivel, Park Jong |
| Circulating cell-free DNA, SLC5A8 and SLC26A4 hypermethylation, BRAF(V600E): A non-invasive tool panel for early detection of thyroid cancer. Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2013 Oct 67 (8): 723-30. Zane Mariangela, Agostini Marco, Enzo Maria Vittoria, Casal Ide Eric, Del Bianco Paola, Torresan Francesca, Merante Boschin Isabella, Pennelli Gianmaria, Saccani Andrea, Rubello Domenico, Nitti Donato, Pelizzo Maria Ro |
| Genome-wide copy number analysis reveals candidate gene loci that confer susceptibility to high-grade prostate cancer. Urologic oncology 2017 09 35 (9): 545.e1-545.e11. Poniah Prevathe, Mohd Zain Shamsul, Abdul Razack Azad Hassan, Kuppusamy Shanggar, Karuppayah Shankar, Sian Eng Hooi, Mohamed Zahur |
| Hypermethylated RASSF1 and SLC5A8 promoters alongside BRAF mutation as biomarkers for papillary thyroid carcinoma. Journal of cellular physiology 2020 2 235 (10): 6954-6968. Khatami Fatemeh, Larijani Bagher, Heshmat Ramin, Nasiri Shirzad, Haddadi-Aghdam Mohammad, Teimoori-Toolabi Ladan, Tavangar Seyed |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: